Palladium‐Catalyzed Methylation of Nitroarenes with Methanol
作者:Lin Wang、Helfried Neumann、Matthias Beller
DOI:10.1002/anie.201814146
日期:2019.4.8
procedure for the synthesis of N‐methyl‐arylamines directly from nitroarenes using methanol as green methylating agent was developed. The key to success is the use of a specific catalyst system consisting of palladium acetate and the ligand 1‐[2,6‐bis(isopropyl)phenyl]‐2‐[tert‐butyl(2‐pyridinyl)phosphino]‐1H‐Imidazole (L1). The generality of this protocol is demonstrated in the synthesis of more than 20
Iron catalyzed oxidative assembly of N-heteroaryl and aryl metal reagents using oxygen as an oxidant
作者:Kun Ming Liu、Lian Yan Liao、Xin Fang Duan
DOI:10.1039/c4cc08494b
日期:——
An equivalent amount of N-heteroaryl and aryl Grignard or lithium reagents, after mediation by an equivalent of titanate, was facilely coupled to furnish N-heteroaryl-aryl compounds under the catalysis of FeCl3/TMEDA at ambient temperature usingoxygen as an oxidant. Most of the common N-heteroaryls were all good candidates, and thus provided a general, green and pratical protocol for the flexible
[EN] PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDYLE À UTILISER EN TANT QU'INHIBITEURS DE BROMODOMAINE
申请人:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
公开号:WO2017174621A1
公开(公告)日:2017-10-12
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
本发明涉及式(I)的化合物及其盐,含有这种化合物的药物组合物,以及它们在治疗中的应用。
[EN] PYRIDINE DICARBOXAMIDE DERIVATIVES AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDINE DICARBOXAMIDE UTILISÉS COMME INHIBITEURS DE BROMODOMAINE
申请人:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
公开号:WO2017202742A1
公开(公告)日:2017-11-30
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.